4beta-Hydroxycholesterol

4beta-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 4beta-hydroxycholesterol is associated with abnormalities such as Kidney Failure, Kidney Failure, Chronic, Respiratory Tract Infections, Immunologic Deficiency Syndromes and Infection. The involved functions are known as Selection, Genetic, Renal function, Anabolism, Inflammation and Cell division phases. 4beta-hydroxycholesterol often locates in Hepatic, Blood, Skin and Microsomes. The associated genes with 4beta-Hydroxycholesterol are CYP3A5 gene, Alleles, TERT gene, CYP3A4 gene and CYP3A7 gene. The related lipids are 4-hydroxycholesterol, Hydroxycholesterols, Promega, Pregnanes and 24-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 4beta-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4beta-Hydroxycholesterol?

4beta-Hydroxycholesterol is suspected in Kidney Failure, Chronic, Kidney Failure, Respiratory Tract Infections, Immunologic Deficiency Syndromes, Infection, Epilepsy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 4beta-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4beta-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4beta-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4beta-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4beta-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4beta-Hydroxycholesterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4beta-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 63
Authors Title Published Journal PubMed Link
Mao J et al. Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A. 2017 Drug Metab. Rev. pmid:27718639
Josephson F et al. CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels. 2008 Eur. J. Clin. Pharmacol. pmid:18458892
Dutreix C et al. Comparison of two endogenous biomarkers of CYP3A4 activity in a drug-drug interaction study between midostaurin and rifampicin. 2014 Eur. J. Clin. Pharmacol. pmid:24839948
Nylén H et al. Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol. 2011 Eur. J. Clin. Pharmacol. pmid:21246351
Hole K et al. Impact of genetic and nongenetic factors on interindividual variability in 4β-hydroxycholesterol concentration. 2017 Eur. J. Clin. Pharmacol. pmid:27975131
Lütjohann D et al. 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. 2009 Int J Clin Pharmacol Ther pmid:19954708
Pataj Z et al. Quantification of oxysterols in human plasma and red blood cells by liquid chromatography high-resolution tandem mass spectrometry. 2016 J Chromatogr A pmid:26607314
Yang Z and Rodrigues AD Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric? 2010 J Clin Pharmacol pmid:20197489
Xu Y et al. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume. 2013 J Pharm Biomed Anal pmid:23948760
van de Merbel NC et al. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma. 2011 J Pharm Biomed Anal pmid:21507593
Ngaimisi E et al. Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment. 2014 J. Antimicrob. Chemother. pmid:25096076
Bodin K et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. 2001 J. Biol. Chem. pmid:11514559
Bodin K et al. Metabolism of 4 beta -hydroxycholesterol in humans. 2002 J. Biol. Chem. pmid:12077124
Hasan M et al. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals. 2016 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:27565568
Suzuki Y et al. Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation. 2013 J. Lipid Res. pmid:23833241
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Breuer O Identification and quantitation of cholest-5-ene-3 beta,4 beta-diol in rat liver and human plasma. 1995 J. Lipid Res. pmid:8656065
Mao J et al. Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound. 2017 Pharm. Res. pmid:28815392
Diczfalusy U et al. 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians. 2008 Pharmacogenet. Genomics pmid:18300941
Niemi M et al. Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin. 2006 Pharmacogenet. Genomics pmid:16847425